TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-27.97%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$436M
AUM Growth
+$436M
(-29%)
Cap. Flow
+$4.27M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
4
Increased
1
Reduced
2
Closed
–
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
$5.04M |
| 2 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
$3.53M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$720K |
| 4 |
Prothena Corp
PRTA
|
$490K |
| 5 |
Equillium
EQ
|
$386K |
Top Sells
| 1 |
Heron Therapeutics
HRTX
|
$3.43M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$2.45M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $198M | 45.38% |
14,047,250
+250,503
| +2% | +$3.53M |
|
|
2
Heron Therapeutics
HRTX
$202M
| $151M | 34.63% |
5,818,541
-132,285
| -2% | -$3.43M |
|
3
Rocket Pharmaceuticals
RCKT
$350M
| $43.9M | 10.08% |
2,965,485
| – | – |
|
|
LJPC
4
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $36.6M | 8.39% |
3,878,893
-260,000
| -6% | -$2.45M |
|
|
5
Puma Biotechnology
PBYI
$257M
| $5.04M | 1.16% |
+247,400
| New | +$5.04M |
|
|
ISEE
6
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $720K | 0.17% |
+600,000
| New | +$720K |
|
|
7
Prothena Corp
PRTA
$445M
| $490K | 0.11% |
+47,610
| New | +$490K |
|
|
8
Equillium
EQ
$61.4M
| $386K | 0.09% |
+47,343
| New | +$386K |
|